Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 506458, 6 pages
http://dx.doi.org/10.1155/2014/506458
Research Article

Differential Hypermethylation of Death-Associated Protein Kinase Promoter in Central Neurocytoma and Oligodendroglioma

1Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
2Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Taiwan
3Department of Neurosurgery, Kaohsiung Medical University Hospital, 100 Shih-Chuan First Road, Kaohsiung, Taiwan
4Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
5Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
6Department of Neurosurgery, University of Virginia, Charlottesville, VA, USA
7Department of Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Received 10 February 2014; Accepted 16 March 2014; Published 27 April 2014

Academic Editor: Hung-Chen Wang

Copyright © 2014 Chia-Li Chung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bertalanffy, K. Roessler, O. Koperek, E. Gelpi, D. Prayer, and E. Knosp, “Recurrent central neurocytomas,” Cancer, vol. 104, no. 1, pp. 135–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Sharma, P. Deb, S. Sharma, and C. Sarkar, “Neurocytoma: a comprehensive review,” Neurosurgical Review, vol. 29, no. 4, pp. 270–285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-L. Chen, C.-C. Shen, J. Wang, C.-H. Lu, and H.-T. Lee, “Central neurocytoma: a clinical, radiological and pathological study of nine cases,” Clinical Neurology and Neurosurgery, vol. 110, no. 2, pp. 129–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. H. Schmidt, O. N. Gottfried, C. S. von Koch, S. M. Chang, and M. W. McDermott, “Central neurocytoma: a review,” Journal of Neuro-Oncology, vol. 66, no. 3, pp. 377–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Agarwal, M. C. Sharma, C. Sarkar et al., “Extraventricular neurocytomas: a morphological and histogenetic consideration. A study of six cases,” Pathology, vol. 43, no. 4, pp. 327–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Chou, W. Varikatt, M. Dexter, and T. Ng, “Extraventricular neurocytoma with atypical features and ganglionic differentiation,” Journal of Clinical Neuroscience, vol. 17, no. 7, pp. 920–922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Cook, S. D. Christie, R. J. B. Macaulay, D. E. Rheaume, and R. O. Holness, “Fourth ventricular neurocytoma: case report and review of the literature,” Canadian Journal of Neurological Sciences, vol. 31, no. 4, pp. 558–564, 2004. View at Google Scholar · View at Scopus
  8. F. L. Gomes, L. R. França, S. T. Zymberg, and S. Cavalheiro, “Central neurocytomas of uncommon locations: report of two cases,” Arquivos de Neuro-Psiquiatria, vol. 64, no. 4, pp. 1015–1018, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G.-F. Yang, S.-Y. Wu, L.-J. Zhang, G.-M. Lu, W. Tian, and K. Shah, “Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature,” American Journal of Neuroradiology, vol. 30, no. 3, pp. 581–585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Amini, T. Roffidal, A. Lee et al., “Central neurocytoma responsive to topotecan, ifosfamide, carboplatin,” Pediatric Blood and Cancer, vol. 51, no. 1, pp. 137–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Jaiswal, M. Vij, D. Rajput et al., “A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma,” Journal of Clinical Neuroscience, vol. 18, no. 3, pp. 334–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Terakawa, T. Tsuruno, K. Ishibashi, Y. Okada, K. Shimotake, and T. Murata, “Central neurocytoma presenting with massive hemorrhage leading to coma—case report,” Neurologia Medico-Chirurgica, vol. 50, no. 2, pp. 139–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hassoun, D. Gambarelli, and F. Grisoli, “Central neurocytoma. An electron-microscopic study of two cases,” Acta Neuropathologica, vol. 56, no. 2, pp. 151–156, 1982. View at Google Scholar · View at Scopus
  14. C. L. Ludwig, M. T. Smith, A. D. Godfrey, and V. W. Armbrustmacher, “A clinicopathological study of 323 patients with oligodendrogliomas,” Annals of Neurology, vol. 19, no. 1, pp. 15–21, 1986. View at Google Scholar · View at Scopus
  15. M. Klysik, J. Gavito, D. Boman, R. N. Miranda, F. Hanbali, and L. E. De Las Casas, “Intraoperative imprint cytology of central neurocytoma: the great oligodendroglioma mimicker,” Diagnostic Cytopathology, vol. 38, no. 3, pp. 202–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. T. Makuria, F. C. Henderson, E. J. Rushing, D.-P. Hartmann, N. Azumi, and M. Ozdemirli, “Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor,” Journal of Neuro-Oncology, vol. 82, no. 2, pp. 199–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Fujisawa, K. Marukawa, M. Hasegawa et al., “Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors,” Journal of Neurosurgery, vol. 97, no. 6, pp. 1350–1355, 2002. View at Google Scholar · View at Scopus
  18. F. J. Rodriguez, R. A. Mota, B. W. Scheithauer et al., “Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma,” Brain Pathology, vol. 19, no. 4, pp. 623–629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Y. K. Tong, H.-K. Ng, J. C. S. Pang, J. Hu, A. B. Y. Hui, and W.-S. Poon, “Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas,” Histopathology, vol. 37, no. 2, pp. 160–165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Okada, H. Yano, Y. Hirose et al., “Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas,” Brain Tumor Pathology, vol. 28, no. 2, pp. 157–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Preusser, H. Budka, K. Rössler, and J. A. Hainfellner, “OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms,” Histopathology, vol. 50, no. 3, pp. 365–370, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Wharton, K. K. Chan, F. A. Hamilton, and J. R. Anderson, “Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study,” Neuropathology and Applied Neurobiology, vol. 24, no. 4, pp. 302–308, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. D'Agostino, M. Salamone, I. di Liegro, and M. L. Vittorelli, “Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis,” International Journal of Oncology, vol. 29, no. 5, pp. 1075–1085, 2006. View at Google Scholar · View at Scopus
  24. A. Lo Cicero, G. Schiera, P. Proia et al., “Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes,” International Journal of Oncology, vol. 39, no. 6, pp. 1353–1357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Brognard and T. Hunter, “Protein kinase signaling networks in cancer,” Current Opinion in Genetics and Development, vol. 21, no. 1, pp. 4–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Michie, A. M. McCaig, R. Nakagawa, and M. Vukovic, “Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer,” The FEBS Journal, vol. 277, no. 1, pp. 74–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Schumacher, A. V. Velentza, and D. M. Watterson, “Death associated protein kinase as a potential therapeutic target,” Expert Opinion on Therapeutic Targets, vol. 6, no. 4, pp. 497–506, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Mittag, D. Kuester, M. Vieth et al., “DAPK promotor methylation is an early event in colorectal carcinogenesis,” Cancer Letters, vol. 240, no. 1, pp. 69–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-I. Kawaguchi, Y. Oda, T. Saito et al., “Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression,” Human Pathology, vol. 35, no. 10, pp. 1266–1271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Tada, M. Wada, K.-I. Taguchi et al., “The association of Death-associated Protein Kinase hypermethylation with early recurrence in superficial bladder cancers,” Cancer Research, vol. 62, no. 14, pp. 4048–4053, 2002. View at Google Scholar · View at Scopus
  31. D. Kuester, T. Guenther, S. Biesold et al., “Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma,” Pathology Research and Practice, vol. 206, no. 9, pp. 616–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Esteller, M. Sanchez-Cespedes, R. Resell, D. Sidransky, S. B. Baylin, and J. G. Herman, “Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients,” Cancer Research, vol. 59, no. 1, pp. 67–70, 1999. View at Google Scholar · View at Scopus
  33. M. Mut, G. Güler-Tezel, M. B. S. Lopes, B. Bilginer, I. Ziyal, and O. E. Özcan, “Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma,” Clinical Neuropathology, vol. 24, no. 5, pp. 225–229, 2005. View at Google Scholar · View at Scopus
  34. D. Gozuacik and A. Kimchi, “DAPk protein family and cancer,” Autophagy, vol. 2, no. 2, pp. 74–79, 2006. View at Google Scholar · View at Scopus